Cytori meldt aangehouden voordelen na 18 maanden in proef met hartceltherapie na hartaanval
June 08, 2011 06:00 ET
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) meldt resultaten na 18 maanden van APOLLO-onderzoek voor Acuut Myocardiaal Infarct (AMI). De resultaten van de 14...
Cytori meldet einen nachhaltigen Nutzen nach 18 Monaten in seiner Studie über die Zelltherapie nach Herzinfarkten
June 08, 2011 06:00 ET
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) gibt die Ergebnisse seiner APOLLO-Studie über akute Myokardinfarkte (AMI) nach 18 Monaten klinischer Tests bekannt....
Cytori informa sobre beneficios continuos a los 18 meses en un estudio de terapia celular cardiaca en ataques al corazón
June 08, 2011 06:00 ET
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori
Therapeutics (NASDAQ: CYTX) da a
conocer los resultados a los 18 meses de su estudio clínico APOLLO sobre infartos agudos de
miocardio (IAM). Los...
Cytori meldet einen nachhaltigen Nutzen nach 18 Monaten in seiner Studie über die Zelltherapie nach Herzinfarkten
June 08, 2011 06:00 ET
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) gibt die Ergebnisse seiner APOLLO-Studie über akute Myokardinfarkte (AMI) nach 18 Monaten klinischer Tests bekannt....
Cytori Receives Cell-Enriched Fat Grafting Patent in Japan
June 02, 2011 08:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jun 2, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has received Japanese Patent No. 4722041 (the '041 patent) covering the preparation of adipose-derived stem and...
NHS National Innovation Centre Identifies Celution(R) as Cost-Effective Innovative Technology for Partial Breast Reconstruction
May 31, 2011 06:00 ET
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND--(Marketwire - May 31, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that results from an economic analysis carried out by the UK NHS National Innovation Centre...
Urinary Incontinence Study Using the Celution(R) System Approved in Japan
May 25, 2011 09:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 25, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has learned that the Japanese Ministry of Health, Labor and Welfare ("MHLW"), the Japanese health regulatory body, has...
Cytori to Present at the Jefferies 2011 Global Healthcare Conference on June 8
May 24, 2011 08:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 24, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8,...
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
May 06, 2011 07:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 6, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has appointed Clyde W. Shores as Executive Vice President of Marketing & Sales where he will lead the Company's...
Cytori Provides Update on Product Pipeline Developments and Reports First Quarter Results
May 05, 2011 16:05 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 5, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX)
provides a quarterly update on its development pipeline and reports
financial results for the first quarter of...